Desjardins Reiterates “Buy” Rating for TSO3 Inc. (TOS)
TSO3 Inc. (TSE:TOS)‘s stock had its “buy” rating reaffirmed by Desjardins in a research note issued on Wednesday. They currently have a C$4.00 price objective on the stock. Desjardins’ target price would indicate a potential upside of 53.26% from the stock’s previous close.
Other equities analysts also recently issued reports about the company. Scotiabank restated an “outperform” rating and issued a C$4.50 target price on shares of TSO3 in a research note on Thursday, July 6th. Canaccord Genuity restated a “buy” rating and issued a C$5.25 target price on shares of TSO3 in a research note on Monday, June 26th. Five equities research analysts have rated the stock with a buy rating, TSO3 has a consensus rating of “Buy” and an average target price of C$4.70.
TSO3 (TSE:TOS) traded up 2.68% on Wednesday, hitting $2.68. The stock had a trading volume of 31,094 shares. The company’s 50 day moving average is $2.63 and its 200 day moving average is $2.90. TSO3 has a 12-month low of $2.05 and a 12-month high of $3.69. The firm’s market cap is $248.55 million.
In other TSO3 news, Director Richard Mark Rumble acquired 22,000 shares of TSO3 stock in a transaction dated Wednesday, August 23rd. The stock was acquired at an average cost of C$2.23 per share, for a total transaction of C$49,060.00.
TSO3 Company Profile
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Stock Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related stocks with our FREE daily email newsletter.